DaVita HealthCare Partner (DVA)
187.50
-5.81 (-3.01%)
NYSE · Last Trade: Oct 30th, 6:36 PM EDT
Detailed Quote
| Previous Close | 193.31 |
|---|---|
| Open | 175.00 |
| Bid | 179.95 |
| Ask | 190.00 |
| Day's Range | 171.15 - 187.91 |
| 52 Week Range | 101.00 - 247.49 |
| Volume | 1,760,640 |
| Market Cap | 12.53B |
| PE Ratio (TTM) | 19.05 |
| EPS (TTM) | 9.8 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 696,535 |
Chart
About DaVita HealthCare Partner (DVA)
DaVita HealthCare Partners is a leading provider of kidney care services in the United States, offering a comprehensive range of dialysis and related healthcare services for patients with chronic kidney failure and end-stage renal disease. The company operates a vast network of outpatient dialysis centers and provides integrated care management and support for patients through various healthcare services, including nutritional counseling, social services, and patient education. DaVita is committed to improving patient outcomes and enhancing the quality of life for those affected by kidney disease while working closely with healthcare providers, payers, and communities to address the evolving challenges of kidney care. Read More
News & Press Releases
Dialysis provider DaVita Inc. (NYSE:DVA) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 4.6% year on year to $3.58 billi...
Via StockStory · October 30, 2026
IKC outperformance helped offset tech investment drag in Q3.
Via The Motley Fool · October 30, 2026
DaVita (NYSE:DVA) reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook. The kidney-care provider said its Integrated Kidney Care business outperformed expectations, though
Via MarketBeat · October 30, 2026
DaVita Inc. (NYSE:DVA) Q3 2026 EPS Beat Overshadowed by Nearly 10% After-Hours Dropchartmill.com
Via Chartmill · October 29, 2026
After-Hours S&P 500 Movers: Mondelez and FedEx Freight Gain, Intel and Reddit Fallchartmill.com
Via Chartmill · October 29, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 4.6% year on year to $3.58 bil...
Via StockStory · October 29, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting earnings this Thursday after the bell. Here’s what investors should know. DaVita beat analysts’ re...
Via StockStory · October 27, 2026
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. (“DaVita” or the “Company”) (NYSE: DVA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · October 27, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · October 26, 2026
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at DaVita (NYSE:DVA) and its pee...
Via StockStory · October 21, 2026
What Happened? Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 7.1% in the afternoon session after Axios reported that the Department of Health and H...
Via StockStory · October 20, 2026
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fallchartmill.com
Via Chartmill · October 20, 2026
S&P 500 Unusual Volume Movers for October 20chartmill.com
Via Chartmill · October 20, 2026
S&P 500 Top Movers: Gainers and Losers From Today's US Sessionchartmill.com
Via Chartmill · October 20, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via StockStory · October 12, 2026
Berkshire is famous for buying stock when shares are notably undervalued.
Via The Motley Fool · October 6, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
Via StockStory · September 30, 2026
DaVita has made Berkshire Hathaway a lot of money. Is Berkshire likely to hold onto the stock?
Via The Motley Fool · September 29, 2026
Discover which S&P500 stocks are making waves on Thursday.chartmill.com
Via Chartmill · September 24, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · September 24, 2026
DaVita, Franklin Resources, and Archer Daniels Midland have each gained more than 30% year to date in 2026, offering investors diversification away from AI-driven stock market gains.
Via MarketBeat · September 21, 2026
What's going on in today's session: S&P500 moverschartmill.com
Via Chartmill · September 17, 2026
DaVita’s 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may hav...
Via StockStory · September 8, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · September 4, 2026
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Via StockStory · September 2, 2026